Pharmacological characterization of MP-412 (AV-412), a dual epidermal growth factor receptor and ErbB2 tyrosine kinase inhibitor
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-12-10
著者
-
Ohya Junichi
Pharmaceuticals Research Division Mitsubishi Pharma Corporation
-
SUZUKI Tsuyoshi
Research Division, Mitsubishi Tanabe Pharma Corporation
-
FUJII Akihiro
Research Division, Mitsubishi Tanabe Pharma Corporation
-
Abe Daisuke
Pharmaceuticals Research Division Mitsubishi Pharma Corporation
-
SUZUKI Tsuyoshi
Pharmaceuticals Research Division, Mitsubishi Pharma Corporation
-
FUJII Akihiro
Pharmaceuticals Research Division, Mitsubishi Pharma Corporation
-
AMANO Yusaku
Pharmaceuticals Research Division, Mitsubishi Pharma Corporation
-
KITANO Yasunori
Pharmaceuticals Research Division, Mitsubishi Pharma Corporation
-
NAKAMURA Hideo
Pharmaceuticals Research Division, Mitsubishi Pharma Corporation
-
Suzuki Tsuyoshi
Research Division Mitsubishi Tanabe Pharma Corporation
-
Amano Yusaku
Pharmaceuticals Research Division Mitsubishi Pharma Corporation
-
Kitano Yasunori
Pharmaceuticals Research Division Mitsubishi Pharma Corporation
-
Fujii Akihiro
Research Division Mitsubishi Tanabe Pharma Corporation
-
Nakamura Hideo
Research Division Mitsubishi Tanabe Pharma Corporation
関連論文
- Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models
- Pharmacological characterization of MP-412 (AV-412), a dual epidermal growth factor receptor and ErbB2 tyrosine kinase inhibitor